Evidence map›Paper›PMID 32398789›Full record

ArticleLeukemia2021

Knockout of the RAS endoprotease RCE1 accelerates myeloid leukemia by downregulating GADD45b.

Christin Karlsson, Murali K Akula, Anna Staffas, Jaroslaw Cisowski, Volkan I Sayin, Mohamed X Ibrahim, Per Lindahl, Martin O Bergo

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Gadd45 Proteins in Immunity 2.0.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Christin KarlssonSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Murali K AkulaSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Anna StaffasSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Jaroslaw CisowskiSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Volkan I SayinSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Mohamed X IbrahimSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Per LindahlWallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
Martin O BergoSahlgrenska Cancer Center, University of Gothenburg, SE-405 30, Gothenburg, Sweden. martin.bergo@ki.se.ORCID http://orcid.org/0000-0002-6915-7140
Sahlgrenska University Hospital · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntigens, DifferentiationDown-RegulationEndopeptidasesGADD45 ProteinsLeukemia, MyeloidMiceMice, KnockoutAntigens, DifferentiationEndopeptidasesGadd45b protein, mouseGADD45 ProteinsRce1 protein, mouse

Identifiers

PMID32398789
OpenAlexW3025855006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.